DK417981A - Fremgangsmaade til fremstilling af 3-aryl-5-isothiazol-derivater - Google Patents

Fremgangsmaade til fremstilling af 3-aryl-5-isothiazol-derivater

Info

Publication number
DK417981A
DK417981A DK417981A DK417981A DK417981A DK 417981 A DK417981 A DK 417981A DK 417981 A DK417981 A DK 417981A DK 417981 A DK417981 A DK 417981A DK 417981 A DK417981 A DK 417981A
Authority
DK
Denmark
Prior art keywords
aryl
preparing
isothiazol
derivatives
isothiazol derivatives
Prior art date
Application number
DK417981A
Other languages
Danish (da)
English (en)
Inventor
J R Beck
R P Gajewski
R E Hackler
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK417981A publication Critical patent/DK417981A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK417981A 1980-09-22 1981-09-21 Fremgangsmaade til fremstilling af 3-aryl-5-isothiazol-derivater DK417981A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/189,435 US4346094A (en) 1980-09-22 1980-09-22 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels

Publications (1)

Publication Number Publication Date
DK417981A true DK417981A (da) 1982-03-23

Family

ID=22697314

Family Applications (1)

Application Number Title Priority Date Filing Date
DK417981A DK417981A (da) 1980-09-22 1981-09-21 Fremgangsmaade til fremstilling af 3-aryl-5-isothiazol-derivater

Country Status (22)

Country Link
US (1) US4346094A (ro)
EP (1) EP0048615B1 (ro)
JP (1) JPS5785379A (ro)
KR (1) KR830007597A (ro)
AR (1) AR229103A1 (ro)
AT (1) ATE7657T1 (ro)
AU (1) AU7551681A (ro)
CS (1) CS228536B2 (ro)
DD (1) DD201790A5 (ro)
DE (1) DE3163900D1 (ro)
DK (1) DK417981A (ro)
ES (1) ES8301225A1 (ro)
FI (1) FI812940L (ro)
GB (1) GB2084573B (ro)
GR (1) GR75046B (ro)
IL (1) IL63890A0 (ro)
NO (1) NO813208L (ro)
PL (1) PL130497B1 (ro)
PT (1) PT73711B (ro)
RO (1) RO82216A (ro)
YU (1) YU227181A (ro)
ZA (1) ZA816549B (ro)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428956A (en) 1980-12-29 1984-01-31 Merck & Co., Inc. 4-Hydroxy-5-substituted-3-(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis
US4431652A (en) * 1980-12-29 1984-02-14 Merck & Co., Inc. 4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis
US4539328A (en) * 1983-03-25 1985-09-03 Fmc Corporation Nematicidal isothiazole derivatives
US4620865A (en) * 1983-11-07 1986-11-04 Eli Lilly And Company Herbicidal and algicidal 1,5-disubstituted-1H-pyrazole-4-carboxamides
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
ZW21687A1 (en) * 1986-12-12 1988-07-20 Hoffmann La Roche Triazine derivatives
DK0513379T3 (da) * 1990-11-30 1996-09-30 Teijin Ltd 2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne
US5294630A (en) * 1992-07-07 1994-03-15 Eli Lilly And Company Treatment of inflammatory bowel disease
US5436258A (en) * 1992-09-09 1995-07-25 Eli Lilly And Company Prevention of bone resorption
MY117352A (en) * 1995-10-31 2004-06-30 Ciba Sc Holding Ag Oximesulfonic acid esters and the use thereof as latent sulfonic acids.
ID21775A (id) * 1996-10-25 1999-07-22 Yoshitomi Pharmaceutical Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
EP1044002A4 (en) 1997-11-07 2003-05-02 Univ Johns Hopkins METHODS FOR THE TREATMENT OF HEART CONTRACTILITY
TW575792B (en) * 1998-08-19 2004-02-11 Ciba Sc Holding Ag New unsaturated oxime derivatives and the use thereof as latent acids
SG78412A1 (en) 1999-03-31 2001-02-20 Ciba Sc Holding Ag Oxime derivatives and the use thereof as latent acids
AU2003206787A1 (en) 2002-02-06 2003-09-02 Ciba Specialty Chemicals Holding Inc. Sulfonate derivatives and the use therof as latent acids
KR20070045272A (ko) * 2004-08-27 2007-05-02 아스텔라스세이야쿠 가부시키가이샤 2-페닐피리딘 유도체
WO2006022375A1 (ja) * 2004-08-27 2006-03-02 Astellas Pharma Inc. 2-フェニルチオフェン誘導体
DE602006018635D1 (de) 2005-10-07 2011-01-13 Astellas Pharma Inc Triarylcarbonsäurederivat
ES2383766T3 (es) 2006-02-24 2012-06-26 Astellas Pharma Inc. Remedio o preventivo para úlcera digestiva
GB2450975B (en) 2007-07-12 2010-02-24 Ciba Holding Inc Yellow radiation curing inks
ES2459722T3 (es) 2009-02-27 2014-05-12 Teijin Pharma Limited Procedimiento para producir un derivado heterocíclico sustituido con fenilo mediante acoplamiento usando un catalizador de metal de transición
WO2010112408A1 (en) 2009-03-30 2010-10-07 Basf Se Uv-dose indicator films
WO2012026565A1 (ja) 2010-08-27 2012-03-01 帝人ファーマ株式会社 パラジウム化合物を用いたカップリング法によるフェニル置換複素環誘導体の製造法
US9310677B2 (en) 2011-01-28 2016-04-12 Basf Polymerizable composition comprising an oxime sulfonate as thermal curing agent
MX363191B (es) * 2013-03-29 2019-03-14 Teijin Pharma Ltd Derivado de pirazol.
KR20170048422A (ko) 2014-08-29 2017-05-08 바스프 에스이 옥심 술포네이트 유도체
EP3288893B8 (de) 2015-04-29 2019-04-10 BSN medical GmbH Mehrstufiges verfahren zur no-herstellung
WO2016174192A1 (de) 2015-04-29 2016-11-03 Bsn Medical Gmbh Medizinische badevorrichtung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1178604A (en) * 1966-03-21 1970-01-21 American Cyanamid Co Novel Pyridinium Salts and Methods for Preparing Same
US3464999A (en) * 1967-07-27 1969-09-02 R & L Molecular Research Ltd Thiadiazolylisothiazoles
GB1180268A (en) * 1967-09-26 1970-02-04 Ici Ltd Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives
GB1192701A (en) * 1968-03-22 1970-05-20 Ici Ltd Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same
US3681498A (en) * 1970-10-19 1972-08-01 American Cyanamid Co Isothiazolyl pyridinium salts as hypoglycemic agents

Also Published As

Publication number Publication date
PT73711B (en) 1982-12-20
KR830007597A (ko) 1983-11-04
AR229103A1 (es) 1983-06-15
JPS5785379A (en) 1982-05-28
ES505678A0 (es) 1982-12-01
ES8301225A1 (es) 1982-12-01
CS228536B2 (en) 1984-05-14
US4346094A (en) 1982-08-24
RO82216A (ro) 1983-07-07
GR75046B (ro) 1984-07-12
EP0048615B1 (en) 1984-05-30
DE3163900D1 (en) 1984-07-05
IL63890A0 (en) 1981-12-31
YU227181A (en) 1983-10-31
PL233103A1 (ro) 1982-12-20
DD201790A5 (de) 1983-08-10
NO813208L (no) 1982-03-23
EP0048615A1 (en) 1982-03-31
GB2084573B (en) 1984-09-12
PT73711A (en) 1981-10-01
PL130497B1 (en) 1984-08-31
ZA816549B (en) 1983-04-27
ATE7657T1 (de) 1984-06-15
GB2084573A (en) 1982-04-15
AU7551681A (en) 1982-04-01
RO82216B (ro) 1983-06-30
FI812940L (fi) 1982-03-23

Similar Documents

Publication Publication Date Title
DK417981A (da) Fremgangsmaade til fremstilling af 3-aryl-5-isothiazol-derivater
DK434381A (da) Fremgangsmaade til fremstilling af substituerede imonodicarboxylsyrer
DK88081A (da) Fremgangsmaade til fremstilling af tetrazolderivater
DK350083A (da) Fremgangsmaade til fremstilling af phenylethanolaminer
DK160679A (da) Fremgangsmaade til fremstilling af derivater af 4-desacetyl-vincaleucoblastin-c-3-carboxhydrazid
DK140480A (da) Fremgangsmaade til fremstilling af mercaptoacyldipeptider
DK229980A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-thienamyciner
DK319281A (da) Femgangsmaade til fremstilling af benzisoselenazoloner
DK343682A (da) Fremgangsmaade til fremstilling af thiazolidinylalkylen-piperazin-derivater
DK416082A (da) Fremgangsmaade til fremstilling af aminopropanolderivater af 2-hydroxy-beta-phenylpropiophenoner
DK479981A (da) Fremgangsmaade til fremstilling af 3-aryl-3-hydroxyphthalimidiner
DK151256C (da) Analogifremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK232080A (da) Fremgangsmaade til fremstilling af hydroxyaminoeburnanderivater
DK300781A (da) Fremgangsmaade til fremstilling af halogenfenylpyridyllylamin-derivater
DK343782A (da) Fremgangsmaade til fremstilling af spirothiazolidinyl-piperazin-derivater
DK188881A (da) Fremgangsmaade til fremstilling af 2-guanidinthiazol-derivater
DK424083D0 (da) Fremgangsmade til fremstilling af anthracyclinglycosider
DK40883A (da) Fremgangsmaade til fremstilling af benzothienylallylaminer
DK231481A (da) Fremgangsmaade til fremstilling af diacetonektetogulonsyre
DK96181A (da) Fremgangsmaade til fremstilling af n-imidazolylderivater af 1-chroman
DK105082A (da) Fremgangsmaade til fremstilling af substituerede trifluormethylphenyl-tetrahydropyridiner
DK501582A (da) Fremgangsmaade til fremstilling af acylcyanider
DK149026C (da) Analogifremgangsmaade til fremstilling af adeninnucleosidderivater
DK548081A (da) Fremgangsmaade til fremstilling af buspiron
DK183880A (da) Fremgangsmaade til fremstilling af hydroxyderivater af isopropyrimidin

Legal Events

Date Code Title Description
ATS Application withdrawn